Search Results 851-860 of 18917 for Neutrophil

1. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) > 1.000/mm3; Absolute lymphocyte count (ALC) ≥ 300/mm3; Platelets ≥ 50.000//mm3; Hemoglobin > 8.0 g/dl. Must have an apheresis ...

2. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 1000/μL;; Platelet count ≥ 100,000/μL (transfusion independent);; Hemoglobin ≥ 8.0 g/dL (may receive RBC ...

3. Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers - Mayo Clinic

   Absolute Neutrophil Count (ANC) ≥ 1,500/mm3 -; Platelet Count ≥ 100,000/mm3 -; Creatinine ≤ 1.5 x ULN Upper Limit of Normal (ULN) OR -; Calculated ...

4. A Study of to Evaluate Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/mcl - Platelets ≥ 100,000/mcl;; Total bilirubin ≤ institutional upper limit of normal (IULN);; AST(SGOT)/ALT(SGPT) ≤ 2.5 ...

5. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1500/μL;; Platelet count ≥100,000/μL;; Hemoglobin ≥8.0 g/dL;; Serum total bilirubin ≤1.5 x upper limit of normal (ULN) or ...

6. Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects with Neuroendocrine Tumors - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1.5 x 109/L. WBC >3000/microliter; Platelet count of ≥100 x 109/L. Total bilirubin level ≤1.5 times institutional upper ...

7. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 mg/dL; Aspartate aminotransferase ...

8. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

   * ECOG performance ≤ 2. * Participants must meet the following organ and marrow function as defined below: * leukocytes ≥ 3000/mcL * absolute neutrophil count ...

9. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

   Absolute neutrophil count ≥ 1,000/mm^3;; Hemoglobin 8 g/dL;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); ...

10. A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma - Mayo Clinic

    Absolute neutrophil count (ANC): ≥ 750/microliters (µL) granulocyte-colony stimulating factor (G-CSF) permitted up to 48 hours prior. Participants with ...